Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats

Masayuki Miyabe, Jeffrey Kirsch, Toshiaki Nishikawa, Raymond C. Koehler, Richard J. Traystman

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objective: We tested the hypothesis that the administration of the competitive N-methyl-D-aspartate (NMDA) receptor antagonist 2R,4R,5S-(2- amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid) (NPC 17742) or cis-4- (phosphonomethyl) piperidine-2-carboxylic acid (CGS 19755) or the noncompetitive NMDA receptor antagonist dizocilpine (MK-801), at the appropriate doses, would all have efficacy in decreasing early postischemic brain injury in a feline model of transient focal ischemia. Design: Prospective, randomized, controlled animal trial. Setting: University research laboratory. Subjects: Forty mixed-breed cats. Interventions: Halothane-anesthetized cats underwent 90 mins of left middle cerebral artery occlusion plus 4 hrs of reperfusion. At 75 mins of ischemia, control cats received intravenous saline (n = 10). Experimental cats (n = 10 in each group) were treated with NPC 17742 (5 mg/kg bolus and 2.5 mg/kg/hr throughout reperfusion), MK-801 (5 mg/kg intravenous bolus), or CGS 19755 (40 mg/kg intravenous bolus) in a randomized fashion. Measurements and Main Results: Microsphere-determined blood flow to the ipsilateral inferior temporal cortex and caudate nucleus decreased to the same extent during ischemia, and recovered to the same extent during early reperfusion, in the four groups. Triphenyltetrazolium-determined injury volume of the ipsilateral caudate nucleus in cats treated with NPC 17742 (105 ± 25 [SEM] mm3), MK-801 (97 ± 22 mm3), and CGS 19755 (97 ± 13 mm3) was less than in control cats (198 ± 21 mm3). Hemisphere injury volumes with NPC 17742 (1209 ± 405 mm3) and MK- 801 (1338 ± 395 mm3) were less than that value in controls (2193 ± 372 mm3), whereas injury volume with CGS 19755 (1553 ± 519 mm3) treatment did not attain significance (p <.09). Conclusions: NMDA receptor activation during reperfusion may contribute to the progression of injury in ischemic border regions after 90 mins of transient focal ischemia in the cat. At the doses chosen, there appear to be no major differences in therapeutic efficacy for competitive and noncompetitive NMDA receptor antagonists.

Original languageEnglish (US)
Pages (from-to)1037-1043
Number of pages7
JournalCritical Care Medicine
Volume25
Issue number6
DOIs
StatePublished - Jun 1997
Externally publishedYes

Fingerprint

selfotel
N-Methyl-D-Aspartate Receptors
Dizocilpine Maleate
Cats
Ischemia
Brain
Reperfusion
Caudate Nucleus
Wounds and Injuries
Middle Cerebral Artery Infarction
Felidae
Halothane
Temporal Lobe
Carboxylic Acids
Microspheres
Brain Injuries
Randomized Controlled Trials
NPC 12626
Research

Keywords

  • Cerebral blood flow
  • CGS 19755
  • Excitatory amino acids
  • Middle cerebral artery occlusion
  • MK-801
  • NPC 17742
  • Sematosensory evoked potential

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats. / Miyabe, Masayuki; Kirsch, Jeffrey; Nishikawa, Toshiaki; Koehler, Raymond C.; Traystman, Richard J.

In: Critical Care Medicine, Vol. 25, No. 6, 06.1997, p. 1037-1043.

Research output: Contribution to journalArticle

Miyabe, Masayuki ; Kirsch, Jeffrey ; Nishikawa, Toshiaki ; Koehler, Raymond C. ; Traystman, Richard J. / Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats. In: Critical Care Medicine. 1997 ; Vol. 25, No. 6. pp. 1037-1043.
@article{71501ec069b243e4b8c4878c986314f7,
title = "Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats",
abstract = "Objective: We tested the hypothesis that the administration of the competitive N-methyl-D-aspartate (NMDA) receptor antagonist 2R,4R,5S-(2- amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid) (NPC 17742) or cis-4- (phosphonomethyl) piperidine-2-carboxylic acid (CGS 19755) or the noncompetitive NMDA receptor antagonist dizocilpine (MK-801), at the appropriate doses, would all have efficacy in decreasing early postischemic brain injury in a feline model of transient focal ischemia. Design: Prospective, randomized, controlled animal trial. Setting: University research laboratory. Subjects: Forty mixed-breed cats. Interventions: Halothane-anesthetized cats underwent 90 mins of left middle cerebral artery occlusion plus 4 hrs of reperfusion. At 75 mins of ischemia, control cats received intravenous saline (n = 10). Experimental cats (n = 10 in each group) were treated with NPC 17742 (5 mg/kg bolus and 2.5 mg/kg/hr throughout reperfusion), MK-801 (5 mg/kg intravenous bolus), or CGS 19755 (40 mg/kg intravenous bolus) in a randomized fashion. Measurements and Main Results: Microsphere-determined blood flow to the ipsilateral inferior temporal cortex and caudate nucleus decreased to the same extent during ischemia, and recovered to the same extent during early reperfusion, in the four groups. Triphenyltetrazolium-determined injury volume of the ipsilateral caudate nucleus in cats treated with NPC 17742 (105 ± 25 [SEM] mm3), MK-801 (97 ± 22 mm3), and CGS 19755 (97 ± 13 mm3) was less than in control cats (198 ± 21 mm3). Hemisphere injury volumes with NPC 17742 (1209 ± 405 mm3) and MK- 801 (1338 ± 395 mm3) were less than that value in controls (2193 ± 372 mm3), whereas injury volume with CGS 19755 (1553 ± 519 mm3) treatment did not attain significance (p <.09). Conclusions: NMDA receptor activation during reperfusion may contribute to the progression of injury in ischemic border regions after 90 mins of transient focal ischemia in the cat. At the doses chosen, there appear to be no major differences in therapeutic efficacy for competitive and noncompetitive NMDA receptor antagonists.",
keywords = "Cerebral blood flow, CGS 19755, Excitatory amino acids, Middle cerebral artery occlusion, MK-801, NPC 17742, Sematosensory evoked potential",
author = "Masayuki Miyabe and Jeffrey Kirsch and Toshiaki Nishikawa and Koehler, {Raymond C.} and Traystman, {Richard J.}",
year = "1997",
month = "6",
doi = "10.1097/00003246-199706000-00022",
language = "English (US)",
volume = "25",
pages = "1037--1043",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Comparative analysis of brain protection by N-methyl-D-aspartate receptor antagonists after transient focal ischemia in cats

AU - Miyabe, Masayuki

AU - Kirsch, Jeffrey

AU - Nishikawa, Toshiaki

AU - Koehler, Raymond C.

AU - Traystman, Richard J.

PY - 1997/6

Y1 - 1997/6

N2 - Objective: We tested the hypothesis that the administration of the competitive N-methyl-D-aspartate (NMDA) receptor antagonist 2R,4R,5S-(2- amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid) (NPC 17742) or cis-4- (phosphonomethyl) piperidine-2-carboxylic acid (CGS 19755) or the noncompetitive NMDA receptor antagonist dizocilpine (MK-801), at the appropriate doses, would all have efficacy in decreasing early postischemic brain injury in a feline model of transient focal ischemia. Design: Prospective, randomized, controlled animal trial. Setting: University research laboratory. Subjects: Forty mixed-breed cats. Interventions: Halothane-anesthetized cats underwent 90 mins of left middle cerebral artery occlusion plus 4 hrs of reperfusion. At 75 mins of ischemia, control cats received intravenous saline (n = 10). Experimental cats (n = 10 in each group) were treated with NPC 17742 (5 mg/kg bolus and 2.5 mg/kg/hr throughout reperfusion), MK-801 (5 mg/kg intravenous bolus), or CGS 19755 (40 mg/kg intravenous bolus) in a randomized fashion. Measurements and Main Results: Microsphere-determined blood flow to the ipsilateral inferior temporal cortex and caudate nucleus decreased to the same extent during ischemia, and recovered to the same extent during early reperfusion, in the four groups. Triphenyltetrazolium-determined injury volume of the ipsilateral caudate nucleus in cats treated with NPC 17742 (105 ± 25 [SEM] mm3), MK-801 (97 ± 22 mm3), and CGS 19755 (97 ± 13 mm3) was less than in control cats (198 ± 21 mm3). Hemisphere injury volumes with NPC 17742 (1209 ± 405 mm3) and MK- 801 (1338 ± 395 mm3) were less than that value in controls (2193 ± 372 mm3), whereas injury volume with CGS 19755 (1553 ± 519 mm3) treatment did not attain significance (p <.09). Conclusions: NMDA receptor activation during reperfusion may contribute to the progression of injury in ischemic border regions after 90 mins of transient focal ischemia in the cat. At the doses chosen, there appear to be no major differences in therapeutic efficacy for competitive and noncompetitive NMDA receptor antagonists.

AB - Objective: We tested the hypothesis that the administration of the competitive N-methyl-D-aspartate (NMDA) receptor antagonist 2R,4R,5S-(2- amino-4,5-(1,2-cyclohexyl)-7-phosphonoheptanoic acid) (NPC 17742) or cis-4- (phosphonomethyl) piperidine-2-carboxylic acid (CGS 19755) or the noncompetitive NMDA receptor antagonist dizocilpine (MK-801), at the appropriate doses, would all have efficacy in decreasing early postischemic brain injury in a feline model of transient focal ischemia. Design: Prospective, randomized, controlled animal trial. Setting: University research laboratory. Subjects: Forty mixed-breed cats. Interventions: Halothane-anesthetized cats underwent 90 mins of left middle cerebral artery occlusion plus 4 hrs of reperfusion. At 75 mins of ischemia, control cats received intravenous saline (n = 10). Experimental cats (n = 10 in each group) were treated with NPC 17742 (5 mg/kg bolus and 2.5 mg/kg/hr throughout reperfusion), MK-801 (5 mg/kg intravenous bolus), or CGS 19755 (40 mg/kg intravenous bolus) in a randomized fashion. Measurements and Main Results: Microsphere-determined blood flow to the ipsilateral inferior temporal cortex and caudate nucleus decreased to the same extent during ischemia, and recovered to the same extent during early reperfusion, in the four groups. Triphenyltetrazolium-determined injury volume of the ipsilateral caudate nucleus in cats treated with NPC 17742 (105 ± 25 [SEM] mm3), MK-801 (97 ± 22 mm3), and CGS 19755 (97 ± 13 mm3) was less than in control cats (198 ± 21 mm3). Hemisphere injury volumes with NPC 17742 (1209 ± 405 mm3) and MK- 801 (1338 ± 395 mm3) were less than that value in controls (2193 ± 372 mm3), whereas injury volume with CGS 19755 (1553 ± 519 mm3) treatment did not attain significance (p <.09). Conclusions: NMDA receptor activation during reperfusion may contribute to the progression of injury in ischemic border regions after 90 mins of transient focal ischemia in the cat. At the doses chosen, there appear to be no major differences in therapeutic efficacy for competitive and noncompetitive NMDA receptor antagonists.

KW - Cerebral blood flow

KW - CGS 19755

KW - Excitatory amino acids

KW - Middle cerebral artery occlusion

KW - MK-801

KW - NPC 17742

KW - Sematosensory evoked potential

UR - http://www.scopus.com/inward/record.url?scp=0030951354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030951354&partnerID=8YFLogxK

U2 - 10.1097/00003246-199706000-00022

DO - 10.1097/00003246-199706000-00022

M3 - Article

C2 - 9201058

AN - SCOPUS:0030951354

VL - 25

SP - 1037

EP - 1043

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 6

ER -